TRHC-logo fin.png
Tabula Rasa HealthCare Chief Strategic Growth Officer to Present at Innovation Showcase
18 mars 2019 08h00 HE | Tabula Rasa HealthCare, Inc.
“Advancing Value through the Science of Personalized Medication Management” MOORESTOWN, N.J., March 18, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) Chief Strategic Growth...
TRHC-logo fin.png
Tabula Rasa HealthCare to Participate in Upcoming Investor Conference
08 mars 2019 10h00 HE | Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., March 08, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced...
TRHC-logo fin.png
Tabula Rasa HealthCare Appoints New Member to its Board of Directors
06 mars 2019 08h00 HE | Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., March 06, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, appointed former Assistant...
TRHC-logo fin.png
Tabula Rasa HealthCare Announces Acquisition of PrescribeWellness Expanding its Medication Risk Mitigation Offering
05 mars 2019 16h05 HE | Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., March 05, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced...
TRHC-logo fin.png
Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2018 Operating Results
28 févr. 2019 16h40 HE | Tabula Rasa HealthCare, Inc.
2018 Revenue of $204.3 million, growth of 53%; 4Q 2018 Revenue of $57.3 million, growth of 32%Provides initial 2019 financial outlook MOORESTOWN, N.J., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa...
Jacques Turgeon, BPharm, PhD, TRHC Chief Scientific Officer and CEO
CEO of TRHC’s New Research & Development Institute to Present at National University of Singapore
25 févr. 2019 08h00 HE | Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that...
Jacques Turgeon, BPharm, PhD, TRHC Chief Scientific Officer and CEO
Tabula Rasa HealthCare Announces Launch and Location of New Scientific Precision Pharmacotherapy Research & Development Institute
21 févr. 2019 10h33 HE | Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J. and ORLANDO, Fla., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety,...
TRHC-logo fin.png
Tabula Rasa HealthCare Expands MTM Software Reach outside the United States through a License to a Canadian Pharmacy Organization Focused on Enhancing Health Outcomes
21 févr. 2019 07h30 HE | Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J. and MARKHAM, Ontario, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication...
TRHC-logo fin.png
Tabula Rasa HealthCare Announces Closing of Offering of 1.75% Convertible Notes and Exercise in Full of Option to Purchase Additional Notes
12 févr. 2019 17h09 HE | Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) (“TRHC”) today announced the closing of its previously announced offering of $325 million principal...
TRHC-logo fin.png
Tabula Rasa Healthcare to Announce Fourth Quarter and Full Year 2018 Operating Results and Host Conference Call on Thursday, February 28, 2019
11 févr. 2019 10h00 HE | Tabula Rasa HealthCare, Inc.
MOORESTOWN, N.J., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, will release its fourth...